C188892Level 4
Recombinant Human Hyaluronidase/Pertuzumab/Trastuzumab Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of a fixed-dose combination of three agents: recombinant human hyaluronidase, pertuzumab and trastuzumab, that may be used in the treatment of breast cancer.
**Synonyms:** - Hyaluronidase-zzxf/Pertuzumab/Trastuzumab Regimen - Pertuzumab and Trastuzumab hyaluronidase monotherapy - Pertuzumab/Trastuzumab/Hyaluronidase-zzxf Regimen - Phesgo Regimen - Recombinant Human Hyaluronidase-Pertuzumab-Trastuzumab Regimen
GET
/api/v1/systems/nci_thesaurus/nodes/C188892Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.